International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Clinical Evaluation Of Katibasti with Agnitaila in Gridhrasi (Sciatica) – A Case Series
| Author(s) | Dr. ALLAPPA S KUMBAR, Dr. PRASHANTH KUMAR, Dr. NITIN V, Prof. Dr. BASAVARAJA G SARAGANACHARI |
|---|---|
| Country | India |
| Abstract | Gridhrasi, classified as a Vataja Nanatmaja Vyadhi, closely resembles Sciatica in modern science and presents with symptoms such as radiating low back pain, Stambha, Ruk, Toda, and Spandana. Though primarily Vata-dominant, Kapha involvement is also noted in certain cases, leading to subtypes—Vataja and Vatakaphaja Gridhrasi. Snigdha Swedana in the form of Katibasti is a widely practiced therapeutic procedure for Vata-related conditions of the lower back. The present study, titled "Clinical Evaluation Of Katibasti With Agnitaila In Gridhrasi (Sciatica)", aimed to evaluate the efficacy of Agnitaila in managing Gridhrasi. Objectives: Primary: To see the therapeutic efficacy of Katibasti with Agnitaila through Clinical Gradings, VAS Scale, SLR Test & ODI Questionnaire method. Secondary: To enhance the quality of life by reducing the pain, dependency & improving the functionality. Methodology: A total of 15 patients were selected and Katibasti was administered for 45 minutes daily for 10 days using Agnitaila Observations & Interpretation: The highest incidence was observed in the 36–45 age group (60%), with a slightly higher prevalence in males (53.3%). The majority of patients were IT professionals and homemakers, with Vataja Gridhrasi being more common (70%). Majority of the patients were having <1 year duration of illness. Discussion & Results: Statistical analysis within the groups showed significant improvement in all parameters, with Agnitaila showing better results in relieving Ruk, Stambha and Toda, slightly less effective in reducing Spandana and Gaurava. Conclusion: The findings suggest that Katibasti with Agnitaila is a safe and effective treatment for Gridhrasi, providing significant symptomatic relief without worsening Kaphaja symptoms. |
| Keywords | Gridhrasi; Swedana; Katibasti; Agnitaila |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 1, January-February 2026 |
| Published On | 2026-02-13 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals